We continuously screen national and international markets for innovative healthcare and biotech products.
Before we send a product
to our laboratories, a
structured (economic, regulatory, scientific)
preliminary assessment is carried out.
In cooperation
with highly qualified
German partner laboratories, we test every product comprehensively, precisely and transparently.
The results
will be analyzed in detail
and presented to the
investment team
as well as Wolfgang
Steiner personally
for a decision.
Following a positive
decision, we develop the next
strategic
steps together with the
manufacturer.